950 POSTER The prognostic significance of c-erbB-2, p53 and bcl-2 immunoexpression in patients with epithelial ovarian cancer treated with paclitaxel and platinum

首页> 外文期刊>European Journal of Cancer Supplements >950 POSTER The prognostic significance of c-erbB-2, p53 and bcl-2 immunoexpression in patients with epithelial ovarian cancer treated with paclitaxel and platinum

【24h】

950 POSTER The prognostic significance of c-erbB-2, p53 and bcl-2 immunoexpression in patients with epithelial ovarian cancer treated with paclitaxel and platinum

机译：950 POSTER紫杉醇联合铂类药物治疗上皮性卵巢癌患者中c-erbB-2，p53和bcl-2免疫表达的预后意义

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2005年第2期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Prognostic significance of HER-2, p53 and Bcl-2 in patients with epithelial ovarian cancer. [J] . Malamou-Mitsi V, Crikoni O, Timotheadou E, Anticancer Research: International Journal of Cancer Research and Treatment . 2007,第2期

机译：HER-2，p53和Bcl-2在上皮性卵巢癌患者中的预后意义。
2. Prognostic Significance of Preoperative Prognostic Nutritional Index in Epithelial Ovarian Cancer Patients Treated with Platinum-Based Chemotherapy [J] . Miao Yi, Li Shuangdi, Yan Qin, Oncology research and treatment. . 2016,第11期

机译：铂类化学疗法治疗卵巢上皮癌患者术前预后营养指标的预后意义
3. P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome. [J] . Gadducci A, Di Cristofano C, Zavaglia M, Anticancer Research: International Journal of Cancer Research and Treatment . 2006,第1B期

机译：晚期浆液性上皮性卵巢癌患者P53基因状态与对紫杉醇加铂类化学疗法的反应及长期临床疗效相关。
4. Systemic pelvic and paraaortic lymphadenectomy and prognostic significance in advanced epithelial ovarian malignancies: A meta-analysis and research [C] . Dong Yanlei, Zhang Shiqian 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：全身性盆腔和主动脉旁淋巴结清扫术对晚期上皮性卵巢恶性肿瘤的预后意义：一项荟萃分析和研究
5. Prognostic significance of some clinical, histopathological and biological parameters for survival of node-negative breast cancer patients treated in University Medical centre Maribor in the period 2000-2009 [D] . Fokter Dovnik, Nina. 2017

机译：2000 - 2009年在大学医疗中心管理中的节点阴性乳腺癌患者中临床，组织病理学和生物学参数的预后意义
6. Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy [O] . Marta Smoter, Lubomir Bodnar, Bartlomiej Grala, 2013

机译：Tau蛋白作为紫杉醇/铂一线化疗治疗上皮性卵巢癌患者的潜在预测指标
7. The prognostic significance and immuno-expression of survivin, mutant p53 and bcl-2 in 92 cases of epithelial ovarian cancer [O] . 2020

机译：92例上皮性卵巢癌92例Survivin，突变P53和Bcl-2的预后意义和免疫表达

950 POSTER The prognostic significance of c-erbB-2, p53 and bcl-2 immunoexpression in patients with epithelial ovarian cancer treated with paclitaxel and platinum

著录项

相似文献

相关主题

期刊订阅